The patented traditional Chinese medicine, Shuganning injection, could selectively upregulate heme oxygenase 1 (HO-1) expression in TNBC cells, leading to lipid iron pool accumulation and ferroptosis occurrence, inhibiting breast cancer tissue growth both in vivo and in vitro (95). This evidence concerns the gene HMOX1 and breast carcinoma.